aod9604 clinical trials obesity Understanding AOD 9604: The Science of the “Fat-Burning” Peptide Fragment Order AOD 9604 (3mg) |

The most common AEs reported during the study were: Headache (6 times) Fatigue (4) Hypoglycemia unspecified (3) Dizziness (3) Nasopharyngitis (2) Cough (2) Lethargy (1) Tonsillitis (1) Abdominal pain unspecified (1) Application site reaction unspecified (1) Injection site bruising (1) Rhinitis seasonal (1) Anorexia (1) Injection site pain (1) None of the AEs were of severe intensity and there was no observable trend between the different treatment groups with respect to the incidence of certain AEs

SAM was obtained from Sigma Aldrich and nicotinamide from Fluka Analytical (Kwazulu Natal, South Africa

Ipamorelin for beginners: Dosage, benefits, and how to stack (2025)

B12 is not reliably present in plant foods (algae and fermented foods are unreliable sources)

Recommendations are for informational purposes only

Its important to talk to your doctor before taking this peptide for dosage instructions and recommendations